跳至主要内容
临床试验/DRKS00011567
DRKS00011567已完成不适用

Small Intestinal Bacterial Overgrowth (SIBO) as pathogenetic mechanism of Functional Dyspepsia (FD) - SIBO and FD

Hepatogastroenterology Unit, Second Department of Internal Medicine – Propaedeutic Research Institute and Diabetes Center0 个研究点目标入组 483 人开始时间: 2017年3月16日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
483

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 80 Years(—)
性别
All

入选标准

  • Enrolled patients (Arm1) should have clinical evidence of Functional Dyspepsia.
  • Healthy controls (Arm 2) consist of participants that undergo upper gastrointestinal endoscopy in
  • terms of iron deficiency anaemia investigation and have no evidence of any liver disease. Arm 3 comprises of IBS (Irritable Bowel Syndrome) patients, which has been associated with SIBO (Small Intestinal Bacterial Overgrowth). Their epidemiological characteristics, duodenal fluid culture results, total bacterial count and peripheral blood samples are already available in our database.

排除标准

  • 1. Age <18 years
  • 2. Ongoing alcohol overconsumption
  • 3. Recent use of antibiotics (within the last 3 months)
  • 4. Recent upper gastrointestinal bleeding
  • 5. Inability to provide informed consent
  • For patients group (Arm 1):
  • 1. No indications of other systematic diseases ie viral hepatitis, metabolic diseases or cancer

研究者

发起方
Hepatogastroenterology Unit, Second Department of Internal Medicine – Propaedeutic Research Institute and Diabetes Center

相似试验